Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Return on Assets [ROA] (2013 - 2026)

Updated

Skye Bioscience's Return on Assets [ROA] was -331.64% in Q2 2026, down 259.18 percentage points from -72.46% a year earlier and down 91.41 percentage points from the prior quarter.

Analysis

Skye Bioscience (SKYE) Return on Assets [ROA] (2013 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Skye Bioscience came in at -110.66%, down 47.93 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of +170.41 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -62.73% in FY2024 (+294.92 pp), -357.64% in FY2023 (-152.21 pp), -205.44% in FY2022 (-69.37 pp) and -136.06% in FY2021 (+145.00 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q3 2023.
  • Compared with a year earlier, Return on Assets [ROA] has declined for five straight quarters, with an average year-over-year change of +3.91 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2024 (a gain of 577.86 percentage points); the worst was Q2 2023 (a drop of 446.94 percentage points).
  • Per Business Quant data, SKYE's Return on Assets [ROA] in the three quarters before Q2 2026 was -240.23% (Q1 2026), -160.62% (Q4 2025) and -109.60% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 8.08%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 7.32%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 1.87%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.36%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 9.80%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -7.67%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 2.00%
10 Skye Bioscience 5.38 Mn -52.34 Mn - -467.75%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -467.75%
Jun 30, 2026 -331.64%
Mar 31, 2026 -240.23%
Dec 31, 2025 -160.62%
Sep 30, 2025 -109.60%
Jun 30, 2025 -72.46%
Mar 31, 2025 -47.47%
Dec 31, 2024 -34.44%
Sep 30, 2024 -25.17%
Jun 30, 2024 -46.45%
Mar 31, 2024 -70.23%
Dec 31, 2023 -273.34%
Sep 30, 2023 -483.36%
Jun 30, 2023 -624.31%
Mar 31, 2023 -315.46%
Dec 31, 2022 -325.24%
Sep 30, 2022 -308.89%
Jun 30, 2022 -177.37%
Mar 31, 2022 -110.22%
Dec 31, 2021 -79.12%
API Access

Skye Bioscience Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SKYE&period=max&api_key=YOUR_API_KEY